Inner Mongolia Furui Med Sci (SHE:300049) — Market Cap & Net Worth
Market Cap & Net Worth: Inner Mongolia Furui Med Sci (300049)
Inner Mongolia Furui Med Sci (SHE:300049) has a market capitalization of $1.95 Billion (CN¥13.34 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #6369 globally and #1422 in its home market, demonstrating a -15.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inner Mongolia Furui Med Sci's stock price CN¥50.36 by its total outstanding shares 264975900 (264.98 Million). Analyse 300049 cash generation efficiency to see how efficiently the company converts income to cash.
Inner Mongolia Furui Med Sci Market Cap History: 2015 to 2026
Inner Mongolia Furui Med Sci's market capitalization history from 2015 to 2026. Data shows growth from $1.17 Billion to $1.95 Billion (5.28% CAGR).
Inner Mongolia Furui Med Sci Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inner Mongolia Furui Med Sci's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.71x
Inner Mongolia Furui Med Sci's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.72x
Inner Mongolia Furui Med Sci's market cap is 17.72 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $795.08 Million | $826.99 Million | $121.05 Million | 0.96x | 6.57x |
| 2017 | $509.71 Million | $823.33 Million | $61.11 Million | 0.62x | 8.34x |
| 2018 | $390.07 Million | $867.03 Million | $35.42 Million | 0.45x | 11.01x |
| 2019 | $292.36 Million | $831.74 Million | $43.39 Million | 0.35x | 6.74x |
| 2020 | $313.91 Million | $807.53 Million | $61.91 Million | 0.39x | 5.07x |
| 2021 | $565.49 Million | $898.48 Million | $95.47 Million | 0.63x | 5.92x |
| 2022 | $939.80 Million | $1.01 Billion | $97.89 Million | 0.93x | 9.60x |
| 2023 | $1.69 Billion | $1.15 Billion | $101.56 Million | 1.46x | 16.64x |
| 2024 | $1.22 Billion | $1.35 Billion | $113.29 Million | 0.91x | 10.80x |
| 2025 | $2.73 Billion | $1.59 Billion | $154.09 Million | 1.71x | 17.72x |
Competitor Companies of 300049 by Market Capitalization
Companies near Inner Mongolia Furui Med Sci in the global market cap rankings as of May 4, 2026.
Key companies related to Inner Mongolia Furui Med Sci by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Inner Mongolia Furui Med Sci Historical Marketcap From 2015 to 2026
Between 2015 and today, Inner Mongolia Furui Med Sci's market cap moved from $1.17 Billion to $ 1.95 Billion, with a yearly change of 5.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.95 Billion | -28.48% |
| 2025 | CN¥2.73 Billion | +123.24% |
| 2024 | CN¥1.22 Billion | -27.64% |
| 2023 | CN¥1.69 Billion | +79.84% |
| 2022 | CN¥939.80 Million | +66.19% |
| 2021 | CN¥565.49 Million | +80.15% |
| 2020 | CN¥313.91 Million | +7.37% |
| 2019 | CN¥292.36 Million | -25.05% |
| 2018 | CN¥390.07 Million | -23.47% |
| 2017 | CN¥509.71 Million | -35.89% |
| 2016 | CN¥795.08 Million | -32.11% |
| 2015 | CN¥1.17 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Inner Mongolia Furui Med Sci was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.95 Billion USD |
| MoneyControl | $1.95 Billion USD |
| MarketWatch | $1.95 Billion USD |
| marketcap.company | $1.95 Billion USD |
| Reuters | $1.95 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more